Artificial Intelligence In Precision Medicine Market
Artificial Intelligence In Precision Medicine Market Forecasts to 2030 - Global Analysis By Offering (Hardware, Services, and Software), Technology (Machine Learning, Context-aware Computing, Natural Language Processing, Computer Vision, Querying Method and Deep Learning), Application and By Geography.
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $1.73 BN |
|
Projected Year Value (2030) |
US $13.3 BN |
|
CAGR (2023 - 2030) |
13.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Artificial Intelligence In Precision Medicine Market is accounted for $1.73 billion in 2023 and is expected to reach $13.3 billion by 2030 growing at a CAGR of 33.8% during the forecast period. Artificial intelligence (AI) in precision medicine involves the use of genomic data about an individual to develop personalised medicine. With this data, it is possible to create treatment plans for patients. Artificial intelligence (AI) in medicine is used to analyse complex medical data by approximating human cognition with the help of algorithms and software. AI technology can help make this process faster and cheaper, which in turn is expected to improve the efficiency of pharmaceutical and biotechnology companies.
According to the National Institutes of Health (NIH) report, in 2023, 1.9 million new cancer cases and 609,820 cancer deaths are projected to occur in the U.S. only. Therefore, integration of AI in oncology is expected to contribute to more accurate and faster diagnosis of cancer, leading to enhanced patient outcomes.
Market Dynamics:
Driver:
Increasing prevalence of cancer
Cancer incidence rates continue to escalate, necessitating more effective and precise treatment strategies. AI, with its advanced algorithms and machine learning capabilities, has emerged as a potent tool to tackle the complexities of cancer diagnosis, prognosis, and personalised treatment. AI has a significant impact on the diagnosis of cancer through image analysis, assisting in the very accurate early detection of cancers and metastases. Moreover, AI-driven predictive modelling helps anticipate disease outcomes and patient responses to various treatments, facilitating tailored and optimised therapeutic approaches. AI ensures that patients receive the most appropriate and effective treatments, ultimately improving survival rates and enhancing the overall quality of cancer care.
Restraint:
High cost
The development and deployment of AI technologies for precision medicine entail substantial expenses in terms of research, data collection, algorithm development, computational resources, and specialised expertise. The cost-intensive processes include building and maintaining cutting-edge computing infrastructure, evaluating vast amounts of healthcare data, and developing AI models. These financial barriers pose challenges in accessibility and affordability, limiting the widespread adoption and implementation of AI in precision medicine and ultimately affecting its potential to revolutionise healthcare outcomes and personalised treatments.
Opportunity:
Technological advancements
AI has evolved with remarkable progress, leveraging machine learning, deep learning, natural language processing, and predictive analytics to revolutionise how medical data is analysed and utilised in the context of precision medicine. AI-powered tools can assist in diagnosis, drug discovery, patient risk assessment, and treatment optimisation, enhancing overall patient care and outcomes. Moreover, the continuous enhancement of AI algorithms and models is fostering the creation of more accurate, efficient, and reliable AI solutions for precision medicine. As technology continues to evolve, the capabilities of AI in precision medicine are expected to expand further, contributing to more effective, timely, and personalised healthcare interventions, ultimately revolutionising the way medicine is practiced and improving patient outcomes on a global scale.
Threat:
Security risks
The integration of AI requires vast amounts of patient-specific information, including genetic data and medical records. This abundance of personal data makes the sector a prime target for cyber threats, data breaches, and unauthorised access. Protecting this sensitive information from malicious attacks and ensuring compliance with stringent privacy regulations poses a significant challenge. Security breaches can compromise patient confidentiality, erode trust in AI-powered systems, and deter both healthcare providers and patients from adopting these potentially transformative technologies. These threats are hampering market growth.
Covid-19 Impact
The COVID-19 pandemic had a positive impact on AI in the precision medicine market. The healthcare sector had noticed a greater focus on using AI technologies to deal with the problems the pandemic had brought up. During the COVID-19 crisis, AI was essential in areas including diagnosis, the development of treatments, the discovery of new drugs, and patient management. Additionally, the use of AI algorithms has made it possible to analyse huge databases for a precise and quick diagnosis of COVID-19 cases. AI-powered solutions have facilitated the development of potential therapeutics and vaccines by identifying drug candidates and expediting the drug repurposing process, this has produced promising opportunities.
The Software segment is expected to be the largest during the forecast period
The Software segment is estimated to hold the largest share, due to a rapid adoption of software solutions based on artificial intelligence in precision medicine by organisations, healthcare payers, patients, and providers. The growth is also attributable to the expanding applications of AI technology in the healthcare industry, including telemedicine, robotic surgery, clinical trials, cybersecurity, dosing error reduction, virtual assistants, and clinical trials. Additionally, government and commercial initiatives also fuel the segment's expansion. Several companies provide software services that estimate cancer progression using an ML algorithm based on in-depth knowledge of scientific prediction, helping to effectively anticipate cancer progression as a response to therapy.
The Neurology segment is expected to have the highest CAGR during the forecast period
The Neurology segment is anticipated to have lucrative growth during the forecast period, due to the rising prevalence of neurological conditions such as epilepsy, dementia, migraines, Alzheimer's, and brain tumours. Growth in the sector is also being fuelled as rising demand for artificial intelligence which is able to treat patients affected by strokes by providing precision treatment. AI enhances brain surgery's preoperative, postoperative, and intraoperative phases. These elements are propelling segment growth.
Region with largest share:
North America commanded the largest market share during the extrapolated period due to the region's high consumer spending power on their health and well-being, rapid growth in investment associated with research and development-related activities, the presence of a strong healthcare infrastructure in countries like the United States and Canada, and its dominance in the market for artificial intelligence in precision medicine in 2022. Moreover, the existence of multiple well-known manufacturers of AI software and systems, as well as greater government initiatives to support start-up’s usage of AI, will also hasten the growth of the sector.
Region with highest CAGR:
Europe is expected to witness profitable growth over the projection period. The need for enhancing and discovering infections in their early stages is rising as a result of the rising frequency of chronic diseases and the growing older population. Countries within the region are actively embracing AI technologies to enhance healthcare outcomes. AI is being utilised to interpret vast medical datasets, personalise treatments, and optimise drug discovery processes. Various companies are implementing strategies to gain a competitive advantage over others. Additionally, collaborative efforts among academia, industry, and healthcare providers are fostering the growth of AI in precision medicine, positioning Europe as a key player in this transformative healthcare domain.
Key players in the market
Some of the key players in the Artificial Intelligence In Precision Medicine Market include BioXcel Therapeutics Inc., Intel Corporation, Insilico Medicine, Microsoft Corporation, NVIDIA Corporation, Sensely, Inc., Alphabet Inc. (Google), IBM, AceTech, Enlitic Inc, GE Healthcare, AstraZeneca, Sanofi, Microsoft Corporation, Welletok Inc., General Vision, Atomwise Inc., Caption Health, Zephyr AI and Berg Health.
Key Developments:
In March 2023, Enlitic, Inc. announced the launch of Enlitic Curie 1.3, an AI-based platform that hosts Curie|ENCOG and Curie|ENDEX applications. This launch makes it easier for radiology departments to improve department-wide workflows.
In November 2022, Google partnered with iCAD, Inc. The collaboration aims to improve breast cancer detection and risk assessment in the short term. Furthermore, the partnership would focus on increasing connectivity to mammography technology via cloud-based solutions.
In September 2022, NVIDIA announced collaboration with Harvard and MIT's Broad Institute. By bringing NVIDIA's computing and AI tools to the institute's Terra cloud platform, the partnership aims to assist academic researchers and pharmaceutical companies in gaining AI-enabled computing power to extract large quantities of healthcare data.
In September 2022, GE Healthcare launched an artificial intelligence-powered Cath lab, Optima IGS 320. The release is expected to offer intelligent imaging to assist patients and cardiologists with personalized therapy protocols.
In August 2022, Sanofi and Atomwise joined a partnership. As per this collaboration, the companies targeted to make the development of drug discovery more cost-effective and effective.
Offerings Covered:
• Hardware
• Services
• Software
Technologies Covered:
• Machine Learning
• Context-aware Computing
• Natural Language Processing
• Computer Vision
• Querying Method
• Deep Learning
Applications Covered:
• Oncology
• Neurology
• Cardiology
• Respiratory
• Ophthalmology
• Nephrology
• Otorhinolaryngology
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Artificial Intelligence In Precision Medicine Market, By Offering
5.1 Introduction
5.2 Hardware
5.3 Services
5.4 Software
6 Global Artificial Intelligence In Precision Medicine Market, By Technology
6.1 Introduction
6.2 Machine Learning
6.3 Context-aware Computing
6.4 Natural Language Processing
6.5 Computer Vision
6.6 Querying Method
6.7 Deep Learning
7 Global Artificial Intelligence In Precision Medicine Market, By Application
7.1 Introduction
7.2 Oncology
7.3 Neurology
7.4 Cardiology
7.5 Respiratory
7.6 Ophthalmology
7.7 Nephrology
7.8 Otorhinolaryngology
7.9 Other Applications
8 Global Artificial Intelligence In Precision Medicine Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 BioXcel Therapeutics Inc.
10.2 Intel Corporation
10.3 Insilico Medicine
10.4 Microsoft Corporation
10.5 NVIDIA Corporation
10.6 Sensely, Inc.
10.7 Alphabet Inc. (Google)
10.8 IBM
10.9 AceTech
10.10 Enlitic Inc
10.11 GE Healthcare
10.12 AstraZeneca
10.13 Sanofi
10.14 Microsoft Corporation
10.15 Welletok Inc.
10.16 General Vision
10.17 Atomwise Inc.
10.18 Caption Health
10.19 Zephyr AI
10.20 Berg Health
List of Tables
1 Global Artificial Intelligence In Precision Medicine Market Outlook, By Region (2021-2030) ($MN)
2 Global Artificial Intelligence In Precision Medicine Market Outlook, By Offering
3 Global Artificial Intelligence In Precision Medicine Market Outlook, By Hardware
4 Global Artificial Intelligence In Precision Medicine Market Outlook, By Services
5 Global Artificial Intelligence In Precision Medicine Market Outlook, By Software
6 Global Artificial Intelligence In Precision Medicine Market Outlook, By Technology
7 Global Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning
8 Global Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing
9 Global Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing
10 Global Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision
11 Global Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method
12 Global Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning
13 Global Artificial Intelligence In Precision Medicine Market Outlook, By Application
14 Global Artificial Intelligence In Precision Medicine Market Outlook, By Oncology
15 Global Artificial Intelligence In Precision Medicine Market Outlook, By Neurology
16 Global Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology
17 Global Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory
18 Global Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology
19 Global Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology
20 Global Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology
21 Global Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications
22 North America Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
23 North America Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
24 North America Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
25 North America Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
26 North America Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
27 North America Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
28 North America Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
29 North America Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
30 North America Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
31 North America Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
32 North America Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
33 North America Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
34 North America Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
35 North America Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
36 North America Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
37 North America Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
38 North America Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
39 North America Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
40 North America Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
41 North America Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
42 North America Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
43 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
44 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
45 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
46 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
47 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
48 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
49 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
50 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
51 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
52 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
53 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
54 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
55 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
56 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
57 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
58 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
59 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
60 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
61 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
62 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
63 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
64 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
65 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
66 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
67 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
68 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
69 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
70 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
71 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
72 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
73 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
74 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
75 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
76 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
77 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
78 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
79 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
80 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
81 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
82 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
83 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
84 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
85 South America Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
86 South America Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
87 South America Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
88 South America Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
89 South America Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
90 South America Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
91 South America Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
92 South America Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
93 South America Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
94 South America Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
95 South America Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
96 South America Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
97 South America Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
98 South America Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
99 South America Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
100 South America Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
101 South America Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
102 South America Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
103 South America Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
104 South America Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
105 South America Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
106 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
107 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
108 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
109 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
110 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
111 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
112 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
113 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
114 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
115 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
116 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
117 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
118 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
119 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
120 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
121 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
122 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
123 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
124 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
125 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
126 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
List of Figures
List of Figures
Figure 1 Global Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 2 North America Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 3 US Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 4 Canada Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 6 Europe Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 7 Germany Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 8 UK Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 9 Italy Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 10 France Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 11 Spain Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 14 Japan Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 15 China Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 16 India Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 17 Australia Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 21 South America Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 24 Chile Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 28 UAE Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
